This webinar will help patients and caregivers approach this difficult and sometimes confusing conversation with their doctors.
Lacosamide UCB is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in adults, adolescents and children from 4 years of age with epilepsy.
he current study's results indicate that youth with psychogenic non-epileptic seizures present with comparably higher self-reported symptoms of depression and dissociation than youth with epilepsy.
Among women with epilepsy at risk for pregnancy 29.6% used no highly effective contraceptive, including no birth control, withdrawal method, or barrier only.
Genetics
His team’s work thus far has focused on developing and testing their gene therapy tools, and they have found that this tool is able to subdue neurons during epileptic activity.
The aims of this study were to determine the rate of dysfunctional personality patterns before and after epilepsy surgery, their types, and the importance of the epileptogenic zone in a sample of people with refractory epilepsy.
Genetics
Using a next-generation sequencing panel with key high?yield genes and robust analytic sensitivity as a first?tier test early in the diagnostic process, especially for children younger than 5 years, can possibly enable precision medicine approaches in a significant number of individuals with epilepsy.
Pediatric Epilepsy
The drug was developed to treat seizures associated with Dravet syndrome, a rare form of epilepsy characterized by frequent and prolonged seizures.
